Parents define children’s oncology-related palliation and pain relief [Pediatrics Classics Series]
Image: PD 1. When interviews with parents who lost children to cancer were compared to patient hospital records, researchers found...
Hematology/Oncology Classics
Landmark studies in hematology/oncology, organized using 2 Minute Medicine’s The Classics table of contents.
Isolated thrombocytopenia uncommon in children treated for ALL [Pediatrics Classics Series]
Image: PD 1. Among 2239 pediatric patients diagnosed with acute lymphoblastic leukemia, no child met criteria for isolated thrombocytopenia as...
Prophylactic penicillin and reduced septicemia in sickle cell patients [Pediatrics Classics Series]
Image: PD 1. This randomized, placebo-controlled, double-blinded trial demonstrated an 84% reduction in the incidence of pneumococcal septicemia among patients...
The NLST trial: Screening for lung cancer [Classics Series]
Image: PD 1. Low-dose computed tomography screening reduces lung cancer mortality when compared to screening with chest radiography 2. Screening...
Hepatocellular carcinoma screening reduces mortality [Classics Series]
Image: PD 1. Patients at high risk for hepatocellular carcinoma who underwent biannual screening with serum AFP levels and liver...
The EINSTEIN-PE trial: Rivaroxaban to treat pulmonary embolism [Classics Series]
Image: PD 1. Rivaroxaban, an oral factor Xa inhibitor, was non-inferior to standard anticoagulation therapy (i.e. low-molecular weight heparin and...
The EINSTEIN-DVT trial: Rivaroxaban in acute deep-vein thrombosis [Classics Series]
Image: PD 1. Rivaroxaban is non-inferior to standard therapy of enoxaparin and vitamin K antagonist in treating acute, symptomatic deep-vein...
The CHOIR trial: Target lower hemoglobin levels in patients with anemia and chronic kidney disease [Classics Series]
Image: CC/L. academia 1. In patients with anemia and chronic kidney disease, treating with epoetin alfa to a lower hemoglobin target...
The RE-COVER trial: Dabigatran non-inferior to warfarin in treating acute venous thromboembolism [Classics Series]
Image: CC/L. academia 1. The RE-COVER trial demonstrates that treating acute venous thromboembolism with 6 months of dabigatran 150 mg twice...
No survival difference in lumpectomy and mastectomy for breast cancer [Classics Series]
Image: PD 1. In women with stage I or II breast cancer, there was no significant difference in overall survival...
